RT
Healthcare & Life Sciences
R1 Therapeutics
United Statesr1therapeutics.com/
R1 Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About R1 Therapeutics
R1 Therapeutics is a startup based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
R1 Therapeutics is developing first-in-class therapies for kidney disease patients, focusing on AP306, a novel pan phosphate transporter inhibitor to treat hyperphosphatemia in chronic kidney disease patients on dialysis.
Explore R1 Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.